Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
Submitted by
admin
on May 25, 2017 - 8:51am
Source:
Forbes
News Tags:
FDA
Puma Biotechnology
breast cancer
advisory panels
neratinib
Headline:
FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
Do Not Allow Advertisers to Use My Personal information
